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INSERTING DCAS9 AND SINGLE-GUIDE RNAS INTO DROSOPHILA 
 




 Non-coding DNA in the human genome is widely studied to investigate its effect 
on coding DNA and gene expression. Non-coding DNA contains cis-regulatory elements 
that influence transcription of genes upstream, downstream, or nearby. These regulatory 
elements have largely been studied as enhancers that promote the transcription of genes. 
To explore these regulatory elements as silencers, we chose validated bifunctional 
elements to study their silencing capability and their chromatin markers.  
 We used chromatin immunoprecipitation methods with dCas9 to target these 
elements using single-guide RNAs (sgRNAs). We experimented with various cloning 
methods to insert dCas9 into the pUAS vector. We initially planned to use the Gibson 
Assembly method, but after no success, we tried site-directed mutagenesis and traditional 
cloning with restriction enzymes. We were able to successfully insert dCas9 into the 
pUAS vector with traditional cloning, and we were then able to inject the construct into 
Drosophila melanogaster. 
 We designed sgRNAs to target desired elements of DNA that we chose to study 
as cis-regulatory elements. The sgRNA sequences were cloned into the pCFD5 vector 
and injected into another line of flies. The transgenic flies containing the pUAS/dCas9 
plasmid will then be crossed with the flies containing the pCFD5/sgRNA to develop 
offspring that express the target elements and could undergo chromatin pulldown to 
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examine the bifunctional regulation of these DNA elements in cells. Results from a 
quantitative PCR (qPCR) assay on Drosophila expressing the cloned pUAS vector with 
dCas9 and a sgRNA for the white gene showed chromatin pulldown efficiency and 
successful transfection.  
 The Drosophila chromatin targeted by the sgRNAs will be pulled down, 
solubilized, and then analyzed on a western blot to screen for chromatin modifications, 
primarily histone modifications. We can then identify chromatin markers associated with 
elements when they act as silencers in the mesoderm versus when they act as non-
mesodermal enhancers. We can also determine if the silencer acts by interacting with a 
promoter or with an enhancer to repress gene expression. If ENCODE can profile the 
data found in this project, the chromatin markers can act as a predictive tool for the 
identification of silencers.   
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 The majority of the DNA that makes up the entire human genome does not code 
for proteins and is known as non-coding DNA. In the 1970s, the term “junk DNA” 
became popular by geneticist Susumu Ohno who used the term to describe over 90 
percent of the genome (Gregory, 2005). The belief that a majority of the human genome 
was useless was popular for many decades. However, further research in genetics showed 
that non-coding DNA plays a significant role in the transcription of genes. One of the 
essential functions of non-coding DNA includes the role of regulatory elements. 
Regulatory elements have a tremendous impact on coding DNA by influencing the 
transcription of nearby genes.  
In the field of genetics research, these regulatory elements have commonly been 
studied as enhancers that activate the transcription of genes. However, there has not been 
adequate research on how these regulatory elements act as silencers to repress gene 
expression. 
 
History of Genetic Regulatory Elements 
Initially, many scientists thought that the DNA outside the protein-coding regions 
was “junk DNA” which had no known function. In the early 2000s, the National Human 
Genome Research Institute (NHGRI) disproved this belief when they proposed and 
funded the Encyclopedia of DNA Elements (ENCODE) project. The ENCODE project 
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analyzed a small percentage of the once termed “junk DNA” by teaming up with “35 
research labs . . . (to analyze) 44 regions of the genome” (Pennisi, 2012). The project 
detected and analyzed functional elements with many assays, such as RNA-Seq, ChIP-
Seq, DNA methylation, and DNase I hypersensitivity (Figure 1). The ENCODE project 
initially analyzed about one percent of the genome thought to be nonfunctional and 
discovered that these DNA regions play a crucial role in gene expression and regulation, 
which inspired further research. 
 
 
Figure 1. The organization of the ENCODE Consortium. This schematic shows the 
various assays and methods that were used in the ENCODE project to analyze non-
coding regulatory elements. ENCODE = encyclopedia of DNA elements; ChIP-Seq = 
chromatin immunoprecipitation sequencing; FAIRE-Seq = formaldehyde-associated 
isolation of regulatory elements sequencing; DNase-Seq = DNase I hypersensitive site 




Gene Regulatory Elements That Can Enhance or Silence Gene Expression 
 Gene regulatory elements have been studied for quite some time and are 
becoming more popular in research as a diagnostic screening for many illnesses and 
diseases. It was a common belief that a majority of the human genome is not involved in 
gene expression. However, it has since been proved that gene regulatory elements play a 
role in enhancing, silencing, insulating, and promoting gene expression to various nearby 
regions. These regulatory elements act at specific genes by forming a loop that causes the 
different regions of DNA to interact (Li et al., 2015). As shown in Figure 2, the loop 
allows the enhancers or silencers to be near the promoter elements so that it can directly 
influence the transcription of genes (Li et al., 2015). 
 
Figure 2. Cis-regulatory elements and a regulatory domain in the human genome.  
Enhancers and other regulatory elements acting at a promoter by forming a loop and 
enhancing transcription of specific genes. Figure taken from (Maston et al., 2006). 
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Other ways that these enhancers target genes are by localizing factors which act to 
recruit the RNA polymerase or by allowing the enhancer-promoter complexes to interact 
with the appropriate transcription compartment directly (Krivega & Dean, 2012). In 
comparison, regulatory elements that act as silencers have been shown to repress 
transcription by altering the chromatin to a repressive state, either by causing histone 
modifications or by preventing the formation of the preinitiation complex during 
transcription (Maston et al., 2006). Histones are proteins that double-stranded DNA 
(dsDNA) coils around to become more compact, leading to the formation of 
chromosomes. When the DNA is tightly coiled, it is known as heterochromatin, which is 
a repressive state with little or no transcription activity. When the chromatin is coiled 
lightly around the histones, it is in the active state, is “more accessible to transcription,” 









Figure 3. Basic structure of histones and chromatin. The blue spheres represent the 
histone proteins which are wrapped by the dsDNA. The tightly wrapped histones show the 
heterochromatin, whereas the loosely wrapped histones show euchromatin. dsDNA = 
double-stranded DNA. Figure taken from (Sha & Boyer, 2009).  
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The idea that most genes are naturally repressed and require additional 
modifications or factors to activate gene transcription is a common belief. These 
modifications are known to be influenced by the environment, and even though these 
modifications do not change the primary DNA sequence, they can be heritable or non-
heritable (Gemenetzi & Lotery, 2020). The current research focus is to discover the 
factors or modifications associated with the regulatory elements and to determine 
whether it is possible to alter the transcription state of elements by switching from a 
repressed state to an active state by epigenetically modifying these regions. 
 
Epigenetics 
 Epigenetics often controls the regulation or dysregulation of gene expression. The 
National Institutes of Health (NIH) defines epigenetics as “chemical compounds . . . 
added to the entirety of one’s DNA (genome) as a way to regulate the activity 
(expression) of all the genes within the genome” (National Institutes of Health, 2020). 
These chemical compounds allow cells and tissues, which “contain the same genetic 
material,” to behave differently throughout the body as a result of different gene 
expression (Williams, 2013). The most common types of epigenetic modifications that 
influence gene expression are methylation, acetylation, and histone protein modifications. 
The study of epigenetic modifications is vital because there are varying patterns of 
modifications in “different tissues within an individual” and finding commonalities in 
these patterns among different people with the same diseases or disorders can be 
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beneficial in genetic screening and the diagnosis of illnesses (National Institutes of 
Health, 2020). 
 
Regulatory Elements and Disease 
Several human diseases are known to be associated with regulatory elements. It is 
crucial to identify the genetic bases of diseases so that there can be screening methods for 
these illnesses. Although the diseases shown in Figure 4 are known to be caused by 
deletions or mutations rather than epigenetic changes, it is a notable example of how a 
change in regulatory elements can have a significant impact on the expression of genes.  
In addition, recent studies have found that gene enhancers that lose healthy 
regulation, or are “hijacked,” may cause the overexpression of oncogenes, which in turn 
can induce tumorigenesis or metastasis (Franco et al., 2018). This misregulation is 
another example of the crucial roles that the regulatory elements play in expression and 
overall cell development. By studying enhancer activity, enhancer location, transcription 
factors or chemical compounds involved, and target sites of these elements, researchers 
can determine how these enhancers cause cancer and how changes at the genetic level 
can activate other illnesses (Franco et al., 2018). The analysis of how these enhancers 
function is crucial to the understanding of diseases, such as some subtypes of breast 
cancer in which upstream enhancers were shown to regulate downstream genes involved 
in the cancer (Franco et al., 2018). Enhancers and their chromatin modifications have 
been well studied, but to downregulate the overexpression and misregulation of genes, 




Figure 4. Transcriptional regulatory elements involved in human diseases. This 
figure shows that many diseases involving transcriptional regulatory elements have 
mutations in the promoter region, as well as in enhancers and silencers. Mutations in 
these regions can have major impact on the transcription of nearby genes. Figure taken 
from (Maston et al., 2006). 
 
Importance of Studying Regulatory Elements 
 Both the regulation and the expression of genes play a crucial role in cell 
development. Misregulation, such as the overexpression or silencing of genes, can lead to 
various illnesses, including cancer. It is important to be able to enhance expression in 
specific genes to promote transcription, but it is just as essential to be able to silence 
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genes in order to downregulate gene expression during cell development. In this project, 
we focus on bifunctional regulatory elements and the associated chromatin modifications 
present when they act as enhancers versus silencers. Finding signature chromatin markers 
that are specific to tissue-specific genes or the activity state of the genes can act as a 
screening method for certain diseases. The chromatin modifications H3k27me3 and 
H3k9me2 are examples of known chromatin modifications that are used for prognostic 
screenings. An article published in the International Journal of Clinical and 
Experimental Pathology discusses how these chromatin modifications can “act as 
potential biomarkers” to screen for esophageal squamous cell carcinoma (ESCC) (Lin et 
al., 2019). These prognostic markers are just one example of how identifying chromatin 
markers for genes can have a substantial impact on medicine. 
 
Ways to Pull Down Genomic Elements 
 The study of these regulatory elements and their markers requires that we perform 
a chromatin pulldown from the genome. One of the various methodologies used to pull 
down elements was first developed in 1957 and is known as the triple helix (triplex) 
“DNA pull-down procedure” (Isogawa et al., 2018). This method works by adding a 
“third strand” of DNA that is rich with pyrimidine or purine bases complementary to the 
“purine-rich strand in the major groove of double-stranded DNA,” which forms a triplex 
that “allows sequence-specific recognition of DNA” that can be pulled down and studied 
(Isogawa et al., 2018). Another method is the chromatin crosslinking approach (BioTAP-
XL), which crosslinks chromatin with formaldehyde, sonicates and solubilizes the 
 9	
chromatin, and then purifies it using a BioTAP tag containing “a Protein A moiety and a 
(biotinylated) targeting signal” (Alekseyenko et al., 2015). The BioTAP-XL method can 
use transcription activator-like effector (TALE) proteins to target desired elements and 
analyze their tissue-specific chromatin markers (Rogers et al., 2015). In the preliminary 
studies, we used TALE proteins and a dCas9-sgRNA complex to pull down the silencer 
element. The method we are using in this study is the CRISPR (clustered regularly 
interspaced short palindromic repeats)-Cas9 (CRISPR-associated protein 9)-guided 
chromatin immunoprecipitation. The dCas9 endonuclease utilized in this method is an 
inactive mutant of Cas9 that is still able “to bind to the gRNA-guided gene target” but is 
unable to cut into the DNA sequence (Zhang et al., 2016). When the target of interest is 
successfully bound to dCas9, the complex can then be immunoprecipitated (Zhang et al., 
2016). We perform Cas9-guided chromatin immunoprecipitation to target elements in the 
mesoderm of Drosophila melanogaster and to pull down their chromatin. 
 
Drosophila Genome 
The model organism that we use to study silencers and their associated markers is 
Drosophila melanogaster, also known as the fruit fly, and specifically its embryonic 
mesoderm. There are several key reasons why scientists for over a century have chosen 
Drosophila as a model to better understand genetics. The main reason is that about “75% 
of disease-related genes in humans” have an ortholog in Drosophila with approximately 
80% to 90% conservation of the DNA sequence (Pandey & Nichols, 2011). Conservation 
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means that if chromatin markers for silencers are discovered in Drosophila, the same 
markers and elements should be observed in humans.  
Another reason why Drosophila melanogaster is an excellent model organism is 
that it replicates very rapidly. Drosophila can hastily produce “hundreds of identical 
offspring” in a matter of 10 to 12 days, which is more efficient than the period of 
reproduction seen in most mammals (Pandey & Nichols, 2011). In addition, the 
Drosophila genome has a “P element transposon” which has been altered. This 
transposon allows “overexpression and deletion” in various genes and is very beneficial 
in the UAS/Gal4 system, which we take advantage of in our project (Lloyd & Taylor, 
2010). In this project, we primarily study embryonic mesoderm during development 
because it contains transcription regulatory elements that are evolutionarily conserved. 
The ability to cross a fly with an altered gene “downstream of a UAS site” with a fly 
expressing Gal4 results in the binding of Gal4 to UAS and “allows the gene of interest to 
be expressed selectively in desired tissue or tissues” (Lloyd & Taylor, 2010). This 
expression allows the testing of potential bifunctional characteristics of regulatory 




The goal of this project is not only to identify the chromatin marker patterns 
present in silencers for creating a catalog but also to identify how these markers differ in 
mesoderm tissue versus non-mesoderm tissue. These markers could allow the prediction 
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of the presence of these silencers in the genome. The findings from the overall project 
should demonstrate that regulatory elements are not strictly enhancers or silencers but 
rather bifunctional regulatory elements that can act as either depending on the presence of 
co-factors or transcription factors in the specific cell types or tissues. The first goal of the 
project is to clone various vectors with either the dCas9 insert or sgRNAs to target 
elements that can be pulled down and studied, as illustrated in Figure 5. The inactive 
endonuclease, dCas9, targets elements through the direction of site-specific sgRNAs. In 
order to inject the dCas9 endonuclease and the sgRNAs into Drosophila, they must first 




Figure 5. Plasmid cloning to target elements. (A) This diagram shows the workflow of 
inserting dCas9 into the pUAS vector before injecting it into Drosophila. (B) This 
diagram shows the workflow of injecting tRNA-flanked sgRNAs into the pCFD5 vector 
prior to injecting it into Drosophila. Drosophila individually containing the newly 
constructed plasmids will eventually be crossed so the sgRNAs can guide dCas9 to the 
target elements under Gal4 expression. dCas9 = deactivated CRISPR-associated protein 
9; sgRNA = single-guide RNA; tRNA = transfer RNA. 
 
 There are various plasmid cloning methods such as Gibson Assembly, site-
directed mutagenesis, and traditional cloning. Gibson Assembly is a more recently 
discovered cloning method that allows the ligation of a gene of interest into a vector. We 
initially chose this method because it "filters out any potential off-target DNA cleavage 
caused by CRISPR/Cas9,” requires fewer steps, and is said to clone constructs seamlessly 
(Wei et al., 2020). A second cloning method is site-directed mutagenesis. This procedure 
works by using a dsDNA “vector with an insert of interest and two synthetic 
B A 
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oligonucleotide primers that both contain the desired mutation” (Agilent 
Technologies, 2015). The primers are “designed with mutually complementary 5’ 
segments while the 3’ segments are complementary . . . to the template” (Wei et al., 
2020). This method was attempted because it has a mutagenesis efficiency “greater than 
80%” and “relies on homologous recombination . . . to re-circulize plasmids containing 
homologous ends” (Wei et al., 2020). A third method of plasmid cloning, the most 
common method, is traditional cloning which “makes use of restriction enzymes and 
ligation of DNA in vitro” (Stevenson et al., 2013). Although this method is “often 
inefficient and laborious,” traditional cloning proved to be successful when cloning the 
constructs in the silencers project (Iizasa & Nagano, 2006). 
When cloning plasmids, most methods are followed with a DpnI restriction 
enzyme digest. DpnI works by targeting the methylated sites in the sequence GATC 
commonly found in the parent strands and Escherichia coli (E. coli) bacteria strains (New 
England Biolabs [NEB], n.d.). The enzyme digest allows the parent plasmid that does not 
contain the desired mutation to be destroyed, leaving the newly constructed plasmid. 
 
The Silencers Project 
Before joining Dr. Martha Bulyk’s laboratory at Brigham and Women’s Hospital 
(Boston, MA), research scientist Stephen Gisselbrecht, Julian Segert, and others 
completed much preliminary work with enhancer elements in Drosophila. The idea of 
studying chromatin markers on regulatory elements began in Dr. Bing Ren’s laboratory at 
the University of California, San Diego (San Diego, CA). This group was able to identify 
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a “relationship between chromatin modifications at transcriptional enhancers” (Stevenson 
et al., 2013). This profound information has since been profiled in ENCODE and has led 
to the creation of computational models such as ChromHMM, which examines chromatin 
states and “observe(s) their biological functions” (Ernst & Kellis, 2012). This work led to 
our research regarding silencers and their possible associated chromatin markers, which 
have not been as heavily researched as enhancers.  
The Bulyk laboratory began the silencer project when creating an assay that 
allows the screening of tissue-specific silencers, known as silencer FACS-Seq (sFS). This 
new screening technology confirmed the phenomenon of bifunctional regulatory 
elements. The silencing activity of these suspected elements was measured by observing 
green fluorescent protein (GFP) activity of the elements inserted into constructs and 
comparing them to the GFP activity of the ubiquitous enhancers. The silencers 
discovered in sFS will be used as a positive control in quantitative silencer FACS-Seq 
(qsFS) assays to study the activity of non-mesodermal enhancers in mesodermal tissue. 
The results of this experiment will be published by the Bulyk laboratory. On 10 of the 
validated bifunctional elements, the Bulyk laboratory will perform chromatin pulldown 
experiments and analyze the chromatin markers associated with these tissue-specific 
elements. 
During preliminary experiments, the Bulyk laboratory performed BioTAP-XL-
TALE approaches as a way to test chromatin pulldown on the confirmed bifunctional 
element brk_NEE. They were able to successfully transfect Drosophila mesodermal cells 
with a plasmid construct containing a TALE expressed under the Gal4 promotor to target 
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and pull down the chromatin of the element. This element can then act as a control when 
targeting potential silencers and pulling down the chromatin from the embryos. The goals 
of this project are to correctly insert dCas9 and sgRNAs into vectors so that elements 
acting as silencers can be targeted, pulled down, and analyzed for characteristic 
chromatin markers that could become prognostic markers.  




Following the discovery of chromatin markers associated with specific enhancers, 
we have chosen regulatory elements to target and pull down so that we can examine 
chromatin markers associated with silencers. The main goals of this project are (1) to 
create plasmids for the dCas9 endonuclease and sgRNAs and (2) to target and examine 
regulatory elements that could potentially act in a bifunctional manner as both silencers 
and enhancers, focusing on the silencers and their chromatin markers. Before the 
injection of the dCas9 endonuclease and the sgRNAs into Drosophila melanogaster, we 
experimented with various molecular cloning techniques to efficiently and correctly clone 
the desired plasmid constructs. 
By targeting the elements that act as silencers and comparing them with their 
orthologous enhancers in Drosophila ananassae, we can compare the chromatin 
modifications between the two. By identifying modifications that are specific to the 
silencers and to a particular cell or tissue type, we can characterize histone modification 
patterns to the chromatin states of a region in the genome. Because there is high 
conservation of the chromatin markers associated with the genome of Drosophila 
melanogaster to humans, we could potentially use these chromatin markers to screen for 






Getting dCas9 Into Drosophila DNA 
 To target silencers in the Drosophila melanogaster genome, we first ligated the 
dCas9 fragment into the pUAS vector. The dCas9 insert fragment was 4,107 bases, and 
the pUAS vector was 7,890 bases. The initial plan was to use Gibson Assembly (NEB, 
Ipswich, MA) for inserting dCas9, but after no success, we attempted other plasmid 
cloning methods. In all of these cloning techniques, the first step was to amplify the 
dCas9 fragment and the pUAS vector. 
 
PCR Amplifying DNA Fragments 
 The first step was to isolate the plasmid DNA, pUAS, from the bacteria by 
performing a miniprep using a Qiagen kit and protocol (Qiagen Inc., Germantown, MD). 
After isolating the plasmid and measuring the DNA concentration, we then performed a 
polymerase chain reaction (PCR). J. Segert, a current Ph.D. student who previously 
worked on the project, designed the primers for the amplification portion of Gibson 
Assembly. Developed using the program SNAPgene (GSL Biotech, San Diego, CA), the 
primers were 30-40 nucleotides long with complementary overhangs that created a 16 bp 
overlap to allow annealing of the pUAS vector to the dCas9 insert. The designed primers 
consisted of forward and reverse primers for the dCas9 insert and the pUAS vector, as 
well as the N-terminus and C-terminus tagged versions of each.  
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We followed the 50 µL reaction protocol for the Q5 polymerase PCR reaction 
provided by New England Biolabs (NEB, Ipswich, MA). The protocol was 25 µL of Q5 
2x master mix, 2.5 µL of the forward primer, 2.5 µL of the reverse primer, 1 µL of the 
template DNA, and 19 µL of deionized water. We repeated the protocol for the N-
terminus tagged pUAS vector, C-terminus tagged pUAS vector, N-terminus tagged 
dCas9 insert, and C-terminus tagged dCas9 insert. Each reaction cycle in the 
thermocycler consisted of the following: initial denaturation at 98 °C for 30 seconds; 30 
cycles of 98 °C for 7 seconds, 70 °C for 20 seconds, and 72 °C for 25 seconds per 
kilobase (kb); final extension at 72 °C for 2 minutes; and finally holding at 4 °C. After 
the PCR was complete, we ran each PCR reaction product on a 0.7% agarose gel. When 
we observed the correct band sizes, the DNA from the gel bands was extracted and 
purified. After a few trials, we added a step of performing a restriction enzyme digest 
using DpnI in an attempt to increase the DNA concentrations. 
 
Gibson Assembly 
For the Gibson Assembly reaction, the amplified, extracted, and purified DNA 
fragments for the pUAS vector and the dCAs9 insert were calculated into picomoles and 
converted into microliters (µL) using their measured DNA concentrations. The reaction 
required the two DNA fragments, the Gibson Assembly Master Mix (which includes the 
5’ exonuclease, Taq polymerase, DNA ligase, and deoxynucleoside triphosphates 
[dNTPs]), and deionized water. After mixing the DNA fragments, Gibson Assembly 
Master Mix, and deionized water together in a 50 µL microcentrifuge tube, we placed the 
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tube in the thermocycler at 50 °C for 1 hour. After the reaction was complete, we 
transformed competent E. coli cells with the reaction product, plated on agar plates of 
lysogeny broth (LB) and ampicillin (AMP) (LB+AMP plates), and incubated for 12-18 
hours. We screened the colonies on these plates with various primers, including dCas9 
primers and primers explicitly designed for screening which we labeled “N-screen” and 




Another method that was performed in an attempt to anneal the dCas9 insert to 
the pUAS vector was QuikChange site-directed mutagenesis (Agilent Technologies, 
Santa Clara, CA). The mutation we chose was the insertion of restriction enzyme sites, 
AgeI and SpeI, into the pUAS vector by first creating primers that bound to the denatured 
plasmid and were complementary to the opposing strands. The protocol in the 
thermocycler was as follows: 30 seconds at 95 °C, cycles 2-18 at 95 °C for 30 seconds, 
55 °C for 1 minute, and 68 °C for 1 min/kb. After the primers annealed, a DNA 
polymerase extended the strands and allowed the restriction enzyme site to be inserted 
into the plasmid.  
After the mutation was thought to have been inserted into the plasmid, we then 
PCR amplified the new plasmid construct using a Phusion polymerase (NEB, Ipswich, 
MA). This step was followed by a DpnI restriction enzyme digest. We then transformed 
the top 10 competent E. coli cells and screened them to confirm that the restriction 
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enzyme site AgeI or SpeI was inserted into the pUAS vector. This screening was 
completed by performing an AgeI restriction enzyme digest and a SpeI restriction 
enzyme digest, respectively, and running the product on an agarose gel. We also ran a 
PCR product of the uncut vector on the gel as a negative control. 
 
Restriction Enzyme Cloning 
The restriction enzyme site chosen to insert into the plasmid was also engineered 
to flank the dCas9 insert in the phage donor. After both the phage donor with the dCas9 
insert and the backbone with the inserted restriction enzyme site were restriction enzyme-
digested with AgeI (NEB), they were treated with a shrimp alkaline phosphatase (SAP) 
(NEB) to remove the 5’ end phosphate to prevent self-ligation of DNA fragments. After 
the ligation reaction was complete, we then transformed E. coli cells with the newly 
ligated fragments and screened them with various primers and restriction enzyme digests 




We followed a Cas9-guided chromatin immunoprecipitation protocol to target 
elements using sgRNAs. To do so, S. Gisselbrecht (Bulyk laboratory) selected 10 
bifunctional elements. We then designed 3-4 sgRNAs to target each specific element 
(Figure 6). We composed the sgRNAs using various online programs such as 
CHOPCHOP (http://chopchop.cbu.uib.no/), CRISPRscan 
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(https://www.crisprscan.org/?page=gene), and UCSC genome 
(https://genome.ucsc.edu/cgi-bin/hgGateway). These tools helped discover target 
sequences. We focused on the conserved elements between the Drosophila melanogaster 
and Drosophila ananassae.  These regions were avoided so that dCas9 could bind to the 
target without causing off-target effects. Based on these sequences, we were able to 
design sgRNA primers that allowed the cloning of the sgRNAs into the vector. To design 
and clone the primers, we followed the protocol described in the methods of Port and 
Bullock (2016). 
 
Figure 6. Oligonucleotide design for each sgRNA. Each designed guide sequence has a 
top oligonucleotide (oligo) and a bottom oligo that are reverse complimentary to each 
other. The oligos also have four additional bases added to the 5’ end and are desalted for 
purification. sgRNA = single-guide RNA. Figure taken from (Port & Bullock, 2016). 
 
The first step was to digest the pCFD5 vector with the restriction enzyme, BbsI. 
The protocol recommended the digestion of 8 µg of the pCFD5 DNA with 1 µL of BbsI, 
3 µL of a 10x buffer, and the remaining volume consisting of deionized water. The total 
reaction volume was 30 µL, which was incubated at 37 °C for 3 hours. The BbsI-digested 
pCFD5 was run on a 1% agarose gel, band size verified, and then extracted and purified. 
We eluted the product in 25 µL of deionized water and measured the DNA concentration 
with a NanoDrop spectrophotometer (Thermo Fisher Scientific, Waltham, MA). 
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The next step after ordering the designed oligonucleotides (oligos) was to set up 
the phosphorylation and annealing reaction. This step required 1 µL of 100 µM top 
oligonucleotide, 1 µL of 100 µM bottom oligonucleotide, 1 µL of T4 ligation buffer, 6.5 
µL of deionized water, and 0.5 µL of T4 polynucleotide kinase. The reaction mixture was 
incubated at 37 °C for 30 minutes, followed by 95 °C for 5 minutes, and then ramped 
down to 20 °C at a rate of 5 °C per minute. 
After the annealing step was the ligation step. This reaction required 60 ng of 
BbsI-digested pCFD5 (calculated depending on the measured DNA concentration), 1 µL 
of the annealed oligonucleotides diluted 1:20 in distilled and deionized water (ddH2O), 
1.5 µL of 10x T4 ligation buffer, 1 µL of T4 DNA ligase, and remaining X µL of ddH2O 
(up to 15 µL). It was then incubated at room temperature for 30 minutes. Following 
ligation, we then transformed E. coli competent cells by adding 2 µL of the reaction into 
50 µL of the cells. The competent cells were recovered in 700 µL of super optimal broth 
(SOC) media, plated 100 µL on LB+AMP plates, and incubated overnight in a 37 °C 
incubator. The colonies were then Sanger sequenced with a specific primer to confirm the 
insertion and correct orientation of sgRNAs into the pCFD5 vector. 
 
Sanger Sequencing 
 For Sanger sequencing of the colonies, we sent our samples to Dana-
Farber/Harvard Cancer Center (Boston, MA) after following the sample preparation 
protocol posted on their website (https://dnaseq.med.harvard.edu/). According to the 
protocol, we measured the DNA concentrations of the ligation products using a 
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NanoDrop spectrophotometer and placed 10 µL of each diluted ligation reaction product 
on a template plate and 12 µL of the primer on a separate primer plate. The primer used 
to sequence the pCFD5 plasmid for the sgRNA was the U6:3 forward primer sequence 
5’-ACGTTTTATAACTTATGCCCCTAAG-3’ from the methods of Port and Bullock 
(2016).  
 
Chromatin Pulldown  
After the sgRNAs were sequence-verified, we injected the plasmids into the flies. 
To test the dCas9 pulldown efficiency, we crossed the flies with the pCFD5 plasmid 
containing white gene sgRNA and Gal4 with the flies that contained the pUAS plasmid 
with BioTAP-tagged dCas9; flies crossed with Gal4 alone acted as a negative control. 
The resulting progeny then underwent a chromatin pulldown to examine their chromatin 
modifications. We were able to detect if the sgRNA had successfully guided dCas9 to the 
target elements after performing the chromatin pulldown and extraction. Meanwhile, we 
used a validated sgRNA to target the white gene to test the efficiency of the chromatin 
pulldown; the sgRNA was provided by the Ueda Laboratory from the National Institute 
of Genetics (Mishima, Japan) (Shu & Ueda, 2013).  
To extract the chromatin, we added 5 mL of buffer A1 with 1.6% formaldehyde in 
up to 200 mg of dechorionated embryos. Using a loose pestle, we applied five strokes 
before switching to a tight pestle and applying another five strokes. We then exposed the 
embryos to formaldehyde at room temperature for up to 15 minutes, added 0.55 mL of 
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2.5 M glycine, and incubated them at room temperature for 5 minutes before placing on 
ice. 
In the next step, the nuclei were spun down for 5 minutes at 4,000 g, washed three 
times with 3 mL of buffer A1, one time with 3 mL of lysis buffer without sodium dodecyl 
sulfate (SDS), and then resuspended as much as possible in 0.5 mL of lysis buffer. After 
the addition of 0.1% SDS and 0.5% N-Lauroylsarcosine, the embryos were incubated at 4 
°C for 10 minutes while rotating. The remaining nuclei were then sonicated for two 
rounds in a Diagenode Bioruptor (Diagenode Inc., Denville, NJ) to shear the chromatin. 
Each round consisted of 15 cycles alternating the power on and off for 30-second 
intervals, and at the end, the samples were spun at maximum speed for 5 minutes before 
recovering and reserving the supernatant. The pellet was resuspended in 0.5 mL of lysis 
buffer and 0.05% SDS and incubated at 4 °C for 10 minutes while rotating and spinning 
for 5 minutes at maximum speed. We then recovered and pooled the supernatants before 
spinning them at maximum speed for 10 minutes and recovering again. 
After we prepared the chromatin, J. Segert (Bulyk laboratory) performed the 
pulldown by means of immunoprecipitation with immunoglobulin G (IgG) agarose 
beads. These beads bind to the protein A moiety in the BioTAP tag bound to dCas9. This 





 The main goal for this project was to insert the dCas9 and sgRNAs into their 
respective vectors to target regulatory elements. As we worked toward this overarching 
goal, we ran into some issues with Gibson Assembly and the crucial process of inserting 
the dCas9 endonuclease into the pUAS vector. 
 We followed the New England Biolabs (NEB) Gibson Assembly protocol when 
performing the reactions, as shown in Figure 7. The first few times that we attempted the 
Gibson Assembly method, it did not work, so we decided to vary different factors of the 
reaction in an attempt to make it more efficient. In the beginning, we were adding 5 µL of 
the reaction product to the competent cells for cell transformations; however, other lab 
members suggested that we dilute the reaction product before mixing it with the 
competent cells. We then performed a 1:4 dilution on the reaction product and added 2 
µL of that dilution to the competent cells. As an experiment, we tested 5 µL of the 
undiluted reaction in the competent cells, as we had previously been doing, compared 
with 2 µL of the diluted product. The experiment showed that there was an increase in the 
number of colonies on the NEB-provided positive control plate, proving that it increased 
the transformation efficiency. As a result, we continued to use a dilution when 
performing cell transformations. 
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Figure 7. Schematic of the NEB standard Gibson Assembly workflow. This 
schematic demonstrates the Gibson Assembly protocol. Following the cell 
transformations, the colonies were screened with various primers. NEB= New England 
Biolabs; dH2O = deionized water; LB+AMP = lysogeny broth + ampicillin.  
 
 
Troubleshooting PCR Amplification 
 We decided to troubleshoot the PCR protocol before the Gibson Assembly 
reaction in an attempt to increase the DNA concentrations of the dCas9 insert and the 
pUAS vector for optimization. We first began to experiment with the annealing 
temperatures. The annealing temperatures were chosen by using the NEB primer Tm 
(melting temperature) calculator and ranged from 64 °C to 70 °C. Each designated 
temperature was set for each fragment when running the PCR with Q5 polymerase. When 
issues began to rise, we decided to attempt a gradient PCR. The annealing temperature set 
for the gradient PCR ranged from 55 °C to 70 °C. Using this PCR gradient still did not 
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produce the correct band size for the desired DNA fragments, so we examined other 
factors. 
We also explored other polymerases, such as KAPA (Roche Diagnostics, 
Indianapolis, IN) and Phusion instead of the original Q5 polymerase, to get sharper bands 
on the gel and higher DNA concentrations. For each polymerase, we followed the 
respective protocol for the N-tagged and C-tagged dCas9 inserts and ran them on a gel. 
We were able to obtain more pronounced bands on the gel, as well as better DNA 
concentrations when amplifying with the KAPA polymerase, as shown in Figure 8. It is 
important to note that the Phusion polymerase did not give the correct band size of 4.1 kb 
for any of the inserts, and the Q5 polymerase did not give the correct band size for the C-
tagged version of the dCas9 insert. 
 
 
Figure 8. DNA concentrations of the dCas9 insert using different PCR polymerases. 
This figure shows the N-tagged version and the C-tagged version of dCas9 A and dCas9 
B. The two templates of dCas9 were used in an attempt to find the optimal 































version of the dCas9 insert. KAPA polymerase showed the highest DNA concentrations. 
dCas9 = deactivated CRISPR-associated protein; PCR = polymerase chain reaction.    
 
Increasing DNA Concentrations 
In addition to altering the PCR amplification, we evaluated some alternative 
purification methods. The initial gel purification of the DNA began with performing gel 
band extractions of the correct band sizes for the insert and vector. We quickly realized 
that running a gel and purifying the bands were compromising the DNA concentrations, 
which were relatively lower than the recommended amount needed for the Gibson 
Assembly reaction. In an attempt to increase the DNA concentrations, we followed a 
suggestion to purify the PCR product with solid-phase reversible immobilization (SPRI) 
beads instead of the gel. Considering that we had been getting the correct band size for 
the individual fragments after performing the DpnI enzyme digest, the chance of the 
vector self-ligating with itself was unlikely. The SPRI beads function by cleaning up the 
DNA when the beads combine with “polyethylene glycol (PEG) and salt,” which allows 
the carboxyl groups on the surface of the beads to attract and bind to the “negatively 
charged DNA” (Hadfield, 2012). With DNA binding to the beads, excess compounds are 
washed away, leaving a higher DNA concentration of the PCR product. 
After achieving higher DNA concentrations for the dCas9 insert and the pUAS 
vector with the SPRI beads, we attempted Gibson Assembly several more times. We had 
already increased the incubation time to the optimal range of an hour; however, we had 
not attempted different incubation temperatures. While researching alternative incubation 
temperatures, most protocols and scientists mentioned that the recommended temperature 
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of 50 °C was the optimal temperature for Gibson Assembly and that there was not much 
success with other temperatures. Nevertheless, we discovered one paper with a protocol 
called the “Modified Gibson Assembly Protocol” that suggested incubating the reaction 
at “60 °C for 4-8 minutes” before the usual one-hour incubation at 50 °C (Birla & Chou, 
2015). We attempted this “Modified Gibson Assembly Protocol” by altering the 
incubation step and retaining the other steps of the previous protocol. However, we did 
not have success with this modified protocol, as evidenced by the lack of colonies on any 
of the plates. 
Trials with Site-Directed Mutagenesis 
Following multiple unsuccessful Gibson Assembly trials, we briefly attempted 
site-directed mutagenesis. S. Gisselbrecht (Bulyk laboratory) recommended this method 
because he was able to quickly design the required oligonucleotide primers and because 
he had success with the method from previous projects. We followed the QuikChange 
site-directed mutagenesis protocol (Agilent, 2015) illustrated in Figure 9. After we 
believed that the restriction enzyme site had been mutated into the pUAS vector, we 
performed a DpnI digest, transformed E. coli cells, performed enzyme digests to confirm 
the insertion, and then ran them on an agarose gel. We observed that the band sizes on the 
gel were not correct, indicating that the site-directed mutagenesis method was 
unsuccessful. 
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Figure 9. Site-directed mutagenesis workflow. This schematic shows the method of 
site-directed mutagenesis that was performed on both the N-tagged and C-tagged pUAS 
vectors. The restriction enzyme sites that were attempted to be inserted in the vectors 
were the AgeI and SpeI sites. The gel with the results of the enzyme digests showed 
incorrect band sizes for both vectors. The yellow arrow indicates where the bands should 
be, around 7.9 kb. PCR = polymerase chain reaction.   
More Gibson Assembly Attempts 
After the failed attempt with site-directed mutagenesis, Brian Rabe from Dr. 
Constance Cepko’s laboratory (Harvard Medical School, Boston, MA) gave us some of 
his Gibson Assembly Master Mix, which he termed “Enhanced Gibson Assembly.” B. 
Rabe did not disclose the contents of his master mix, except that it contained the 
necessary components of an endonuclease, a ligase, a polymerase, and nucleotides. When 
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using his master mix with his recommended protocol, we noticed that there was an 
increase in the number of colonies on the plates of the competent cells transformed with 
the reaction product. Because we had a large number of colonies, we had to screen them 
to confirm that the cloning was successful. To do so, we PCR amplified the Gibson 
Assembly products with various primers, including the dCas9 primers and other primers 
designed explicitly for screening (N-screen and C-screen primers). S. Gisselbrecht (Bulyk 
laboratory) designed the N-screen and C-screen primers to screen the plasmid for the 
expected ligation site of both fragments instead of just the dCas9 insert. This screening 
primer allowed us to not only detect the dCas9 insertion but also confirm its orientation 
as well. Another screening method that we performed involved restriction enzyme digests 
of the Gibson Assembly product with EcoRI and PvuII; these screenings included an 
uncut version of the vector as a negative control. Some of the screened colonies on the 
agarose gel showed nearly correct band sizes, so we additionally performed enzyme 
digests on these colonies as a second screening and ultimately discovered that none of 
them were correct. Although the “Enhanced Gibson Assembly” method did not work in 
this project, it increased the success of the cell transformations and proved to be more 
efficient than the standard Gibson Assembly protocol. 
 
Success with Traditional Cloning 
Finally, S. Gisselbrecht (Bulyk laboratory) suggested that we try traditional 
cloning. To ensure that neither the insert nor the vector is cut at incorrect sites, the choice 
of the restriction enzyme site to insert is crucial. We chose the AgeI restriction enzyme 
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site to insert into both the N-tagged and C-tagged versions of the pUAS vector (Figure 
10). This restriction enzyme site was selected because it can flank the dCas9 insert 
without cutting it. We then engineered the AgeI restriction enzyme site into the multiple 
cloning site (MCS) of the pUAS vector (Addgene, n.d.). The majority of this procedure 
was performed by S. Gisselbrecht because he had successfully cloned many fragments 




Figure 10. Traditional plasmid cloning workflow. This schematic depicts the method 
of traditional cloning with restriction enzymes. This method includes a restriction enzyme 
digest and ligation of the two fragments. dCas9 = deactivated CRISPR-associated 




The pUAS vector and the dCas9 fragment in the phage donor were PCR amplified 
and restriction enzyme-digested with AgeI to cut the fragments at the desired site and 
with EcoRI and PvuII to screen the fragments. After confirmation that the pUAS vector 
and the phage donor with dCas9 were correctly digested, the two fragments were ready to 
undergo ligation. We were finally able to construct the N-tagged and C-tagged versions 
of the pUAS/dCas9 vector. Figure 11 shows the results of the enzyme digests performed 
on the successfully ligated N-tagged construct. After performing the enzyme digests, both 
whole plasmids were Sanger-sequenced and confirmed to have dCas9 successfully 






Figure 11. Restriction digest gel results. (A) This gel shows restriction enzyme digests 
of the cloned pUAS N-tagged dCas9 vector. Lane 2 is the uncut, empty vector which 
would be around the size of 8 kb, as seen with the green arrow. Lane 3 is the EcoRI-
digested vector which should have band sizes of 940, 1300, and 9600 bases, as seen with 
the orange arrows. Lane 4 is the AgeI-digested vector which shows the individual 
fragment band sizes of 7.9 kb and 4.1 kb, as seen with the blue arrows. Lane 5 is the 
vector digested with PvuII to show the fragment sizes of 1600, 2800, and 7600, as seen 
with the yellow arrows. (B) This gel shows restriction enzyme digests of the cloned 
pUAS C-tagged dCas9 vector. Lanes 2 and 3 on the top portion of the gel show the 
incorrect band sizes of the enzyme-digested vector of one of the clone copies. The bottom 
portion of the gel shows the screening of 8 colonies with dCas9 primers. Colonies E, G, I, 
J, and L all give the correct dCas9 insert amplification at the band size of 4.1 kb, as seen 
with the red arrow. The colonies that showed the correct band sizes for the enzyme 
digests or the dCas9 PCR were sent for whole plasmid sequencing. dCas9 = deactivated 





























































Figure 12. Whole plasmid sequenced pUAS vectors with dCas9 insert. This figure 
shows the (A) pUAS vector with N-terminus tagged version of dCas9 and (B) the pUAS 
vector with C-terminus tagged dCas9. These plasmids were created using the DNA 
sequences returned from the whole plasmid sequencing in the software Serial Cloner 
(Version 2.6.1). Both vectors show important characteristics such as the white gene, the 
UAS promoter, the bioTAP tags, and sites where the screening primers anneal. dCas9 = 
























Figure 12 (continued). 
 
After the plasmids were Sanger sequenced, they were injected into yellow, white 
flies with PhiC31 integrase at the attP40 site on chromosome II. The integrase is under 
the control of the nanos promoter which allows deposition of the mRNA in eggs before 
fertilization. The plasmid was injected into a fly stock containing PhiC31 integrase and 
the wild-type eye gene at the attB site and then crossed with virgin females. We injected 
the flies with the sequence-verified plasmid constructs and determined transformants by 
B 
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observing the color of the eyes. The insertion of the white gene into the attP40 site is 
confirmed in transformant flies that have pale-yellow eyes rather than the mutant white 
color. The pale-yellow eye color was observed in the flies that we injected with the 
pUAS/dCas9 vector. 
The wild-type males with the pUAS plasmid were pulled down and crossed with 
virgin females that contained a balancing chromosome. The balancing chromosome 
allows us to maintain a lethal recessive mutation, as well as a pure stock of flies with 
suppressed wild-type genes. We removed the female virgins and males that expressed the 
plasmid, along with the wild-type red eyes and curly wings. Curly wings are a dominant 
mutation on chromosome II that, when homozygous, is lethal. We then isolated females 
with the plasmid and non-curly wings (wild-type gene), which were then self-crossed. 
Flies with the pUAS vector with the dCas9 insert have recently been collected. 
We will cross them with females containing the Gal4 promoter. The Gal4 promoter is 
present in Drosophila and is used to drive the expression of the pUAS vector in the 
mesoderm. The female virgins with the gal4-expressed plasmids will be crossed with a 
male containing another balancing chromosome. By pulling down males with the gal4-
expressed plasmid and crossing it with a female with a balancing chromosome, we will 
be able to create a pure line of virgin females that have the gal4-expressed pUAS vector 
with the tagged dCas9. 
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Designing sgRNAs to Guide dCas9 to Targets 
The crossbreeding of the pUAS construct was performed by S. Gisselbrecht 
(Bulyk laboratory). During this period, we continued to design sgRNAs and insert them 
into a pCFD5 vector. As mentioned earlier, we attempted to design at least 3 sgRNAs for 
the 10 chosen target elements and composed oligo primers for each of these sequences. 
We chose these elements to study because they are enhancers that can also act as 
silencers, proving to be established bifunctional elements. This information was found 
using the previously mentioned sFS assay and is in the process of being published by the 
Bulyk laboratory. It was necessary to avoid areas of conservation in the genome because 
these regions had been conserved throughout evolution, implying that they are important 
and most likely involved in mechanisms such as transcription factor binding or protein 
interactions (Figure 13). These types of interactions in the genome were avoided to 
minimize off-target effects. After finding potential target sequences that did not have 
dense areas of conservation between Drosophila melanogaster and Drosophila 















Figure 13. Element example from UCSC Genome Browser. This is an example of the 
image for the target element “Rho_NEE_long” from the UCSC (University of California, 
Santa Cruz) Genome Browser that was used to design target sequences. The segment 
named “Cons Elements” (marked by *) helped to select DNA segments that lack magenta 
bars, which represents regions of conservation. This selection method aimed at lowering 




Ligating sgRNA Sequences Into pCFD5 
After we designed and ordered the primers for the top and bottom 
oligonucleotides, we performed the phosphorylation and annealing reaction. The 
designed primers gave the sgRNA sequence necessary to ligate into the pCFD5 vector. 
Following the miniprep of the pCFD5 vector, we digested it with the BbsI restriction 
enzyme, ran the digested vector on an agarose gel, gel-purified the product, and measured 





were relatively low at about 80 ng/µL. Because we had enough product for the ligation 
reactions and the cell transformations, we continued with the process; however, we did 
not get colonies on any of the plates (which included ligation reactions with almost 30 
different sgRNA sequences).  
We began to troubleshoot by trying to increase the DNA concentration of the 
pCFD5 vector. We attempted to midiprep the vector to increase the volume yield 
available for the many ligations we had to perform; however, the DNA concentrations 
were deficient at around 40 ng/µL. We returned to the Qiagen miniprep kit but used a 
newer kit because the previous one might have been outdated. We also let the BbsI 
enzyme digest run longer in the 37 °C incubator. Initially, the enzyme digest ran for 2 
hours, but a lab member suggested to let it run overnight for 16 hours. It was important 
not to go over 16 hours because it would increase the chances of the enzymes possibly 
cleaving at sites other than the restriction enzyme sites and ultimately destroying the 
plasmid. In addition, we decreased the agar percentage of the gel from 1% to 0.7% to 
make the bands sharper so we could be more precise in the gel band DNA extraction and 
purification. As a result of these changes, we were able to get adequate DNA 
concentrations over 100 ng/µL and felt confident about moving forward to perform the 
ligation reactions. 
Ultimately, we carried out the ligation reaction and cell transformations two times 
because the first attempt was unsuccessful. Previous cell transformations had been 
performed with NEB top 10 competent cells with the strain 10-beta competent E. coli. 
However, the recommended cells to be transformed in this protocol were the 5-alpha 
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competent E. coli cells. Both strains of the competent cells contain the recA- and endA- 
genes, which are essential for preventing recombination and endonuclease degradation, 
respectively. Following the protocol recommendation, we used the 5-alpha competent 
cells. During the first trial of the cell transformation, we diluted the transformed cells by 
10-fold before spreading them onto the LB+AMP plates. This first cell transformation 
was unsuccessful in that no colonies appeared on the plates. One notable factor, however, 
was that on removing the plates from what was supposed to be a 37 °C incubator, the 
temperature was 28 °C. Fellow lab members realized that the temperature was changed 
overnight and might have been a factor in the lack of colonies. 
In the second trial, we used undiluted ligation product to transform the cells, 
spread about 200 µL of the transformed cells onto its labeled LB+AMP plate, and 
incubated the plates at 37 °C for 16 hours. We were able to successfully get colonies on 
all the plates. To confirm the correct insertion of each sgRNA in the pCFD5 vector, 
whole plasmid sequencing was applied to the cells transformed by the plasmid constructs. 
We chose two colonies for each sgRNA sequence and miniprepped them before sending 
them for Sanger sequencing. Because of the possibility that we would inject flies with the 
sgRNA vector constructs, we had to miniprep the ligation reaction products with the 
ZymoPURE miniprep kit (Zymo Research, Irvine, CA) rather than the usual Qiagen kit. 
In previous experiments we had observed that the vector constructs miniprepped with the 
Qiagen kit killed the embryos, whereas those miniprepped with the ZymoPURE kit did 
not. As we were unaware of this issue when we began miniprepping the samples, about 
half the correct plasmid sequences had to be processed again using the ZymoPURE kit 
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before injecting the embryos. The results of the Sanger sequencing should follow the 
example in Figure 14. 
 
 
Figure 14. pCFD5 with tRNA-flanked guide RNAs. This schematic shows the inserted 
sgRNAs (also referred to as gRNAs) flanked by tRNAs and under the expression of the 
U6:3 promoter in the pCFD5 vector. It also shows the gRNA inserted into the pCFD5 at 
the BbsI-digested sites. sgRNA= single-guide RNA; gRNA = guide RNA; tRNA = 
transfer RNA. Figure taken from (Port & Bullock, 2016). 
 
 
After getting the sequence results for the whole plasmids, we were able to 
determine that about half the pCFD5 plasmids had the sgRNAs inserted correctly into the 
BbsI-digested sites. The sequencing results showed that the sgRNA sequence for the 
elements Rho_NEE_long, hkb_0.6kbRIRv, PNR_p4, 
ths_Neu4_early_embryonic_enhancer, ind_moduleA, ind_moduleBC, and 




Figure 15. sgRNA Sanger sequencing results. The results from whole plasmids after 
Sanger sequencing were entered into the Serial Cloner (Version 2.6.1) gene editing 
program. The “Element Name” column includes shorthand labels for the target elements. 
When the sgRNAs were successfully ligated into pCFD5 vector, we screened 2 colonies 
of the transformed cells for each designed guide sequence. Columns “Template A” and 
“Template B” are the Sanger sequence results for the 2 colonies of each guide sequence. 
“Correct” means the guide sequence was successfully inserted in the correct location and 
correct orientation; “Incorrect” means the guide sequence was not identified in the vector; 
and “N/A” is for the samples that were lost during the inoculation step of miniprepping. 
sgRNA = single-guide RNA.  
 
 
Recently, S. Gisselbrecht and J. Segert (Bulyk laboratory) conducted experiments 
to confirm that the dCas9 protein was being expressed and that the desired target 
elements were being efficiently pulled down. To test the efficiency of the chromatin 
pulldown, they used validated sgRNAs to target the white gene. We then collected 
offspring that should genetically contain the constructs. The chromatin was extracted and 
purified as described in Methods and then underwent a quantitative polymerase chain 
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reaction (qPCR) assay. The results of the qPCR assay showed that the white gene was 
successfully enriched in the chromatin extracted from the Drosophila embryos which 
expressed the white sgRNA in the N-tagged pUAS vector (Figure 16). This assay shows 
the specificity of the targeting and indicates a significant increase in chromatin 
enrichment of the desired target when the sgRNAs are present in vector versus when the 












Figure 16. qPCR results for chromatin pulldown efficiency. This figure shows the 
qPCR results for 3 genes Brk, Gsb, and White. The Brk and Gsb genes are used as 
controls in this assay, and they represent non-targeted regions of the genome. The graph 
shows the amount of immunoprecipitation for the desired gene targets after performing a 
chromatin pulldown when a sgRNA is absent versus when a sgRNA is present. The blue 
bar is for a Gal4-driven N-tagged pUAS vector with the sgRNA for the desired gene. The 
red bar is for a Gal4-driven pUAS vector without a sgRNA. qPCR = quantitative PCR; 



















brk gsb white 
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The results from this qPCR (Figure 16) also demonstrate that we were able to 
correctly insert dCas9 into the pUAS vector using traditional plasmid cloning with 
restriction enzymes and that we were able to efficiently target the desired elements to pull 
down their chromatin. We can now move forward with injecting the correctly sequenced 
sgRNAs into Drosophila and continue to crossbreed the lineage with Drosophila 
containing the twi:gal4 pUAS vector expressing dCas9 in the mesoderm.  
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DISCUSSION 
Although the initial plan to insert dCas9 into the pUAS vector using Gibson 
Assembly ultimately did not work, we were able to successfully insert the dCas9 
endonuclease into the pUAS vector using traditional cloning. We believe that Gibson 
Assembly did not work in our project because of the fragment sizes. Although the NEB 
protocol mentions using the method on fragment sizes as large as 15 kb, many scientists 
with whom I spoke to had success with Gibson Assembly using smaller fragment sizes 
from 1 to 2 kb. As previously mentioned, our fragment sizes were 4.1 kb and 7.9 kb, 
which may have been too large for optimal efficiency. If in future experiments we return 
to this cloning method, we would design different primers and increase the number of 
bases that create the overlap for annealing. The overlap that our primers created was 
about 16 bases. However, it was mentioned by NEB that overlaps can be up to 40 bases 
and that larger overlaps would decrease the amount of DNA necessary for the reaction. 
This increased overlap would be helpful because one of our problems with this cloning 
method was low DNA concentrations. In this case, we discovered that traditional cloning 
was the most optimal plasmid cloning method for our vectors and DNA fragments. 
Future Directions 
The correctly miniprepped sgRNAs are ready to inject into a yellow, vermillion 
fly with phiC31 integrase at attP on chromosome III. We will inject the sgRNA along 
with attB and the wild-type eye gene. We can then screen for non-vermillion eyes to 
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isolate males with the sgRNA and cross them with virgin females with a balancing 
chromosome. We will screen the offspring from this cross for the stubble gene (present in 
the balancing chromosome) and the wild-type eye gene. The resulting offspring can then 
be self-crossed until the wild-type female with the sgRNA is isolated and kept as a pure 
stock. 
Eventually, crossing flies that contain the Gal4UAS/dCas9 plasmid with flies that 
contain the sgRNA will produce offspring that contains both the Gal4-expressed pUAS 
vector with dCas9, along with the sgRNA. After a pure stock is developed, we can then 
target the desired silencers and pull down the chromatin to study the associated chromatin 
markers with the previously mentioned screening methods. 
As we wait for the transformants with the sgRNAs, we are currently looking into 
a positive control that we could use for the chromatin pulldown. A positive control would 
be beneficial to ensure that the chromatin pulldown is efficient. An element that could act 
as a positive control should be a known repetitive region in the genome. The potential 
elements we are considering when choosing a positive control include telomeric repeats, 
histone clusters, and transposable elements. We will continue to consider these options 
for a positive control when performing the chromatin pulldowns of the targeted elements. 
By performing the chromatin pulldown for the silencers, we will collect the 
embryos at the stage of development when the expression of these elements is the most 
active. We will then perform the mentioned workflow of purifying the chromatin with 
IgG agarose beads, followed by the screening assays. The screening methods include 
western blot, mass spectrometry, ChIP-Seq, and qPCR. 
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These various screening methods will help us identify chromatin markers and 
modifications associated with individual silencers and compare them with their enhancer 
orthologs. The western blot assay allows us to analyze proteins and protein modifications. 
The proteins of focus are histones in the genome and their modifications, as well as 
associated co-repressors and repressors. Mass spectrometry is another assay that will 
permit us to identify co-repressors, repressors, and other post-translational modifications 
(PTMs). If there are specific patterns seen in histone marks across several silencers, we 
can further analyze them with ChIP-Seq. ChIP-Seq is an assay that uses antibodies 
against PTMs and histone characteristics seen across many silencers. The study of the 
enrichment of ChIP-Seq peaks for the chromatin marks in certain groups of silencers 
could allow us to identify patterns that might eventually act as a prediction tool for these 
silencers. Many of these assays will be performed when we detect transformants with the 
Gal4-driven pUAS vector and sgRNAs and pull down the chromatin for our desired 
target elements. 
Meanwhile, we have been attempting in situ staining to confirm the expression of 
the pUAS/dCas9 vector in the mesoderm of transformants. To achieve this, we have been 
discussing different possible antibodies that would be most efficient. This approach 
would allow us to confirm the location of the tagged dCas9 by analyzing the GFP 
fluorescence activity. We will observe GFP activity when performing a qPCR assay on 
the targeted elements, which allows fluorescence to be quantitatively measured. J. Segert 
(Bulyk laboratory) has previously attempted this approach with various antibodies, 
including a secondary IgG antibody that could bind to the protein A moiety in the 
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bioTAP tag bound to dCas9. He tried this method with both an anti-rat antibody and a 
goat antibody, both of which did not bind well to the tag. We will continue to experiment 
with different antibodies that are more efficient in imaging the location of dCas9.  
To discover more chromatin markers associated with silencers, we could analyze 
more enhancers and their ability to act as a silencer in different tissues. By observing 
either non-mesodermal enhancer activity as silencers in mesoderm or mesodermal 
enhancer activity as silencers in non-mesoderm, we can select more elements to study 
their bifunctional potential. We can also continue to use qsFS to screen hundreds of 
regulatory elements at a time, to identify these silencers, and to further study their 
characterizations with assays. 
If chromatin patterns are associated with silencers, ENCODE can profile them, 
and they can then act as a predictive screening tool for the silencers in Drosophila. 
Although we predict the conservation of these target elements in humans, we would have 
to test the conservation of the silencer-associated chromatin marks as well. We could test 
this conservation from Drosophila to humans by performing ChIP-Seq and RNA 
knockout or knockdown assays in human cell cultures. We could also test the silencers 
for their specificity to tissues or cells by studying the elements in different tissues of the 
Drosophila and human cells. The results of this project can be profiled by ENCODE, 
along with the already discovered enhancer data, and together this information can act as 
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